New Therapy Prevents Immune Attack after Stem-Cell Transplant
A midstage clinical trial has shown that a new treatment called CD24Fc may be able to prevent graft-versus-host disease (GVHD), a common immune-related complication of bone marrow transplants. Bone marrow